Production of 8-hydroxy-2'-deoxguanosine in DNA by microsomal activation of tamoxifen and 4-hydroxytamoxifen

Carcinogenesis

Volumn 17, Issue 8, 1996, Pages 1747-1750

  Ye, Qiuping ^a   Bodell, William J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 HYDROXYTAMOXIFEN; 8 HYDROXYDEOXYGUANOSINE; CATALASE; CELL DNA; EDETIC ACID; MANNITOL; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; SODIUM AZIDE; SUPEROXIDE DISMUTASE; TAMOXIFEN;

ANIMAL CELL; ARTICLE; CARCINOGENESIS; CONTROLLED STUDY; DNA DETERMINATION; DRUG ACTIVATION; FEMALE; LIVER MICROSOME; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0029760030     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/17.8.1747     Document Type: Article

References (29)

1. Fischer, B., Constantino, J.P. Redmond, C.K., Fisher, E.R., Wickerham, D.L. and Cronin, W.M. (1994) Endometrial cancer in tamoxifen-treated breast cancer patients: findings from the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-14. J. Natl Cancer Inst., 86, 527-537.
2. Williams, G.M., Iatropoulos, M.J., Djordjevic, M.V. and Kaltenberg, O.P. (1993) The triphenylethylene drug tamoxifen is a strong liver carcinogen in the rat. Carcinogenesis, 14, 315-317.
3. Han, X. and Liehr, J.G. (1992) Induction of covalent DNA adducts in rodents by tamoxifen. Cancer Res., 52, 1360-1363.
4. White, I.N.H., Matteis, F., Davies, A., Smith, L.L., Crofton-Sleigh, C., Venitt, S., Hewer, A. and Phillips, D.H. (1992) Genotoxic potential of tamoxifen and analogues in female Fischer F344/n rats. DBA/2 and C57BL/6 mice and in human MCL-5 cells. Carcinogenesis, 13, 2197-2205.
5. Randerath, K., Bi, J., Mabon, N., Sriram, P. and Moorthy, B. (1994) Strong intensification of mouse hepatic tamoxifen DNA adduct formation by pretreatment with the sulfotransferase inhibitor and ubiquitous environmental pollutant pentachlorophenol. Carcinogenesis, 15, 797-800.
6. Pathak, D.N. and Bodell, W.J. (1994) DNA adduct formation by tamoxifen with rat and human liver microsomal activation systems. Carcinogenesis, 15, 529-532.
7. Mani, C., Gelboin, H.V., Park, S.S., Pearce, R., Parkinson, A. and Kupfer, D. (1993) Metabolism of the antimammary cancer antiestrogenic agent tamoxifen. I. Cytochrome P-450-catalyzed N-demethylation and 4-hydroxylation. Drug Metab. Dispos., 21, 645-656.
8. Pathak, D.N., Pongracz, K. and Bodell, W.J. (1995) Microsomal and peroxidase activation of 4-hydroxy-tamoxifen to form DNA adducts: comparison with DNA adducts formed in Sprague-Dawley rats treated with tamoxifen. Carcinogenesis, 16, 11-15.
9. Pongracz, K., Pathak, D.N., Nakamura, T., Burlingame, A.L. and Bodell, W.J. (1995) Activation of the tamoxifen derivative Metabolite E to form DNA adducts: comparison with the adducts formed by microsomal activation of tamoxifen. Cancer Res., 55, 3012-3015.
10. Liehr, J.G. and Roy, D. (1990) Free radical generation by redox cycling of estrogens. Free Radical Biol. Med., 8, 415-423.
11. Roy, D., Floyd, R.A. and Liehr, J.G. (1991) Elevated 8-hydroxydeoxyguanosine levels in DNA of diethylstilbestrol-treated Syrian hamsters: covalent DNA damage by free radicals genernated by redox cycling of diethylstilbestrol. Cancer Res., 51, 3882-3885.
12. Fridovich, I. (1978) The biology of oxygen radicals. Science, 201, 875-880.
13. Dizdaroglu, M. (1992) Oxidative damage to DNA in mammalian chromatin. Mutat. Res., 275, 331-342.
14. Floyd, R.A. (1990) The role of 8-hydroxyguanine in carcinogenesis. Carcinogenesis, 11, 1447-1450.
15. Shatkin, A.J. (1969) Colorimetric reactions for DNA, RNA and protein determinations. In Habel, K. and Salzman, N.P (eds), Fundamental Techniques in Virology, Academic Press, New York, NY, pp. 231-236.
16. Kasai, H. and Nishimura, S. (1984) Hydroxylation of deoxyguanosine at the C-8 position by ascorbic acid and other reducing agents. Nucleic Acids Res., 12, 2137-2145.
17. Rashba-Step, J. and Cederbaum, A.I. (1994) Generation of reactive oxygen intermediates by human liver microsomes in the presence of NADPH or NADH. Mol. Pharmacol., 45, 150-157.
18. Kolachanna, P., Subrahmanyam V.V., Meyer, K.B., Zhang, L. and Smith, M.T. (1993) Benzene and its phenolic metabolites produce oxidative base damage in HL60 cells in vitro and in the bone marrow in vivo. Cancer Res., 53, 1023-1026.
19. Fischer, W.H. and Lutz, W.K. (1995) Correlation of individual papilloma latency time with DNA adducts, 8-hydroxy-2′-deoxyguanosine and the rate of DNA synthesis in the epidermis of mice treated with 7,12-dimethylbenz[a]anthracene. Proc. Natl Acad. Sci. USA, 92, 5900-5904.
20. Frenkel, K., Wei, L. and Wei, H. (1995) 7,12-Dimethylbenz[a]anthracene induces oxidative DNA modification in vivo. Free Radical Biol. Med., 19, 373-380.
21. Shen, H.-M., Ong, C.-N, Lee, B.-L. and Shi, C.-Y. (1995) Aflatoxin B1-induced 8-hydroxydeoxyguanosine formation in rat hepatic DNA. Carcinogenesis, 16, 419-422.
22. Gutteridge, J.M.C. (1985) Superoxide dismutase inhibits the superoxide-driven Fenton reaction at two different levels. Implications for a wider protective role. FEBS Lett., 185, 19-23.
23. Aruoma, O.I., Halliwell, B., Gajewski, E. and Dizdaroglu, M. (1989) Damage to the bases in DNA induced by hydrogen peroxide and ferric ion chelates. J. Biol. Chem., 264, 20509-20512.
24. Turner, M.J., Fields, C.E. and Everman, D.B. (1991) Evidence for superoxide formation during hepatic metabolism of tamoxifen. Biochem. Pharmacol., 41, 1701-1705.
25. Li, Y., Kuppusamy, P., Zweirer, J.L. and Trush, M.A. (1995) ESR evidence for the generation of reactive oxygen species from the copper-mediated oxidation of the benzene metabolite, hydroquinone: role in DNA damage. Chem.-Biol. Interactions, 94, 101-120.
26. Devasagayam, T.P.A., Steenkeen, S., Obendorf, M.S.W., Schulz, W.A. and Sies, H. (1991) Formation of 8-hydroxy(deoxy)guanosine and generation of strand breaks at guanine residues in DNA by singlet oxygen. Biochemistry, 30, 6283-6289.
27. Bhimani, R.S., Troll, W., Grunberger, D. and Frenkel, K. (1993) Inhibition of oxidative stress in HeLa cells by chemopreventive agents. Cancer Res., 53, 4528-4533.
28. Wiseman, H., Laughton, M., Arnstein, H.R.V., Cannon, M. and Halliwell, B. (1990) The antioxidant action of tamoxifen and its metabolites: inhibition of lipid peroxidation. FEBS Lett., 263, 192-194.
29. Ahotupa, M., Hirsimaki, P., Parssinen, R. and Mantyla, E. (1994) Alterations of drug metabolizing and antioxidant enzyme activities during tamoxifen-induced hepatocarcinogenesis in the rat. Carcinogenesis, 15, 863-868.